Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model.

Roux GL, Jarray R, Guyot AC, Pavoni S, Costa N, Théodoro F, Nassor F, Pruvost A, Tournier N, Kiyan Y, Langer O, Yates F, Deslys JP, Mabondzo A.

Sci Rep. 2019 Nov 5;9(1):16310. doi: 10.1038/s41598-019-52213-6.

2.

In utero exposure to acetaminophen and ibuprofen leads to intergenerational accelerated reproductive aging in female mice.

Rossitto M, Ollivier M, Déjardin S, Pruvost A, Brun C, Marchive C, Nguyen AL, Ghettas A, Keime C, de Massy B, Poulat F, Philibert P, Boizet-Bonhoure B.

Commun Biol. 2019 Aug 13;2:310. doi: 10.1038/s42003-019-0552-x. eCollection 2019.

3.

Dynamical thermal dose models and dose time-profile effects.

Ladjimi MT, Labavić D, Guilbert M, Anquez F, Pruvost A, Courtade E, Pfeuty B, Thommen Q.

Int J Hyperthermia. 2019;36(1):721-729. doi: 10.1080/02656736.2019.1633478.

PMID:
31353987
4.

Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency.

Ullio-Gamboa G, Udobi KC, Dezard S, Perna MK, Miles KN, Costa N, Taran F, Pruvost A, Benoit JP, Skelton MR, Lonlay P, Mabondzo A.

Nanomedicine (Lond). 2019 Jun;14(12):1579-1593. doi: 10.2217/nnm-2019-0059. Epub 2019 Apr 30.

PMID:
31038003
5.

Microenvironment tailors nTreg structure and function.

Schiavon V, Duchez S, Branchtein M, How-Kit A, Cassius C, Daunay A, Shen Y, Dubanchet S, Colisson R, Vanneaux V, Pruvost A, Roucairol C, Setterblad N, Bouaziz JD, Boissier MC, Semerano L, Graux C, Bensussan A, Burny A, Gallo R, Zagury D, Le Buanec H.

Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6298-6307. doi: 10.1073/pnas.1812471116. Epub 2019 Mar 7.

6.

Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.

Clària J, Moreau R, Fenaille F, Amorós A, Junot C, Gronbaek H, Coenraad MJ, Pruvost A, Ghettas A, Chu-Van E, López-Vicario C, Oettl K, Caraceni P, Alessandria C, Trebicka J, Pavesi M, Deulofeu C, Albillos A, Gustot T, Welzel TM, Fernández J, Stauber RE, Saliba F, Butin N, Colsch B, Moreno C, Durand F, Nevens F, Bañares R, Benten D, Ginès P, Gerbes A, Jalan R, Angeli P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL Clif Consortium, Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif).

Hepatology. 2019 Apr;69(4):1686-1701. doi: 10.1002/hep.30363. Epub 2019 Mar 19.

PMID:
30521097
7.

Intergenerational effects on mouse sperm quality after in utero exposure to acetaminophen and ibuprofen.

Rossitto M, Marchive C, Pruvost A, Sellem E, Ghettas A, Badiou S, Sutra T, Poulat F, Philibert P, Boizet-Bonhoure B.

FASEB J. 2019 Jan;33(1):339-357. doi: 10.1096/fj.201800488RRR. Epub 2018 Jul 6.

PMID:
29979629
8.

Methotrexate and BAFF interaction prevents immunization against TNF inhibitors.

Bitoun S, Nocturne G, Ly B, Krzysiek R, Roques P, Pruvost A, Paoletti A, Pascaud J, Dönnes P, Florence K, Gleizes A, Hincelin-Mery A, Allez M, Hacein-Bey-Abina S, Mackay F, Pallardy M, Le Grand R, Mariette X.

Ann Rheum Dis. 2018 Oct;77(10):1463-1470. doi: 10.1136/annrheumdis-2018-213403. Epub 2018 Jun 23.

PMID:
29936438
9.

The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques.

Laforge M, Silvestre R, Rodrigues V, Garibal J, Campillo-Gimenez L, Mouhamad S, Monceaux V, Cumont MC, Rabezanahary H, Pruvost A, Cordeiro-da-Silva A, Hurtrel B, Silvestri G, Senik A, Estaquier J.

J Clin Invest. 2018 Apr 2;128(4):1627-1640. doi: 10.1172/JCI95127. Epub 2018 Mar 19.

10.

A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.

Naret T, Bignon J, Bernadat G, Benchekroun M, Levaique H, Lenoir C, Dubois J, Pruvost A, Saller F, Borgel D, Manoury B, Leblais V, Darrigrand R, Apcher S, Brion JD, Schmitt E, Leroux FR, Alami M, Hamze A.

Eur J Med Chem. 2018 Jan 1;143:473-490. doi: 10.1016/j.ejmech.2017.11.055. Epub 2017 Dec 2.

PMID:
29202409
11.

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients.

Becher F, Ciccolini J, Imbs DC, Marin C, Fournel C, Dupuis C, Fakhry N, Pourroy B, Ghettas A, Pruvost A, Junot C, Duffaud F, Lacarelle B, Salas S.

Sci Rep. 2017 Jun 2;7(1):2714. doi: 10.1038/s41598-017-02821-x.

12.

Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire.

Kroidl A, Ello F, Mgaya J, Lennemann T, Moh R, Maganga L, Eholie S, Pruvost A, Saathoff E, Girard PM, Zuhse R, von Massow F, Anglaret X, Hoelscher M, Danel C; FATI-1 study team.

AIDS. 2017 Feb 20;31(4):501-509. doi: 10.1097/QAD.0000000000001362.

13.

Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.

Bassil F, Fernagut PO, Bezard E, Pruvost A, Leste-Lasserre T, Hoang QQ, Ringe D, Petsko GA, Meissner WG.

Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9593-8. doi: 10.1073/pnas.1609291113. Epub 2016 Aug 1.

14.

Activity of Bisnaphthalimidopropyl Derivatives against Trypanosoma brucei.

Graça NA, Gaspar L, Costa DM, Loureiro I, Thoo-Lin PK, Ramos I, Roura M, Pruvost A, Pemberton IK, Loukil H, MacDougall J, Tavares J, Cordeiro-da-Silva A.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2532-6. doi: 10.1128/AAC.02490-15. Print 2016 Apr.

15.

A limited sampling strategy based on maximum a posteriori Bayesian estimation for a five-probe phenotyping cocktail.

Nguyen TT, Bénech H, Pruvost A, Lenuzza N.

Eur J Clin Pharmacol. 2016 Jan;72(1):39-51.

PMID:
26490357
16.

Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.

Matusali G, Dereuddre-Bosquet N, Le Tortorec A, Moreau M, Satie AP, Mahé D, Roumaud P, Bourry O, Sylla N, Bernard-Stoecklin S, Pruvost A, Le Grand R, Dejucq-Rainsford N.

J Virol. 2015 Jun;89(11):5772-87. doi: 10.1128/JVI.03628-14. Epub 2015 Apr 1.

17.

An optimal LC-MS/MS method for determination of azithromycin in white blood cells: application to pediatric samples.

Legrand T, Elie V, Kotecha S, Junot C, Jacqz-Aigrain E, Pruvost A.

Bioanalysis. 2014 Aug;6(17):2317-28. doi: 10.4155/bio.14.81.

PMID:
25383741
18.

Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.

Murphy DJ, Desjardins D, Dereuddre-Bosquet N, Brochard P, Perrot L, Pruvost A, Le Grand R, Lagatie O, Vanhooren L, Feyaerts M, van Roey J, Malcolm RK.

J Antimicrob Chemother. 2014 Sep;69(9):2477-88. doi: 10.1093/jac/dku160. Epub 2014 May 26.

PMID:
24862093
19.

Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy.

Maksimenko A, Alami M, Zouhiri F, Brion JD, Pruvost A, Mougin J, Hamze A, Boissenot T, Provot O, Desmaële D, Couvreur P.

ACS Nano. 2014 Mar 25;8(3):2018-32. doi: 10.1021/nn500517a. Epub 2014 Feb 26.

20.

Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients.

Domingo P, Mateo MG, Pruvost A, Torres F, Salazar J, Gutierrez Mdel M; Ma Carmen Cabeza, Domingo JC, Fernandez I, Villarroya F, Vidal F, Baiget M, de la Calle-Martín O.

PLoS One. 2013 Jun 26;8(6):e67035. doi: 10.1371/journal.pone.0067035. Print 2013.

21.

Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2).

Hirt D, Ekouévi DK, Pruvost A, Urien S, Arrivé E, Blanche S, Avit D, Amani-Bosse C, Nyati M, Legote S, Ek ML, Say L, McIntyre J, Dabis F, Tréluyer JM.

Antimicrob Agents Chemother. 2011 Jun;55(6):2961-7. doi: 10.1128/AAC.01377-10. Epub 2011 Apr 4.

22.

Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2).

Hirt D, Pruvost A, Ekouévi DK, Urien S, Arrivé E, Kone M, Nerrienet E, Nyati M, Gray G, Kruy LS, Blanche S, Dabis F, Tréluyer JM.

Antimicrob Agents Chemother. 2011 Jun;55(6):2953-60. doi: 10.1128/AAC.01376-10. Epub 2011 Apr 4.

23.

In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery.

Lacombe O, Videau O, Chevillon D, Guyot AC, Contreras C, Blondel S, Nicolas L, Ghettas A, Bénech H, Thevenot E, Pruvost A, Bolze S, Krzaczkowski L, Prévost C, Mabondzo A.

Mol Pharm. 2011 Jun 6;8(3):651-63. doi: 10.1021/mp1004614. Epub 2011 Apr 15.

PMID:
21438632
24.

Association of thymidylate synthase gene polymorphisms with stavudine triphosphate intracellular levels and lipodystrophy.

Domingo P, Cabeza MC, Pruvost A, Torres F, Salazar J, del Mar Gutierrez M, Mateo MG, Fontanet A, Fernandez I, Domingo JC, Villarroya F, Vidal F, Baiget M.

Antimicrob Agents Chemother. 2011 Apr;55(4):1428-35. doi: 10.1128/AAC.01589-10. Epub 2011 Jan 31.

25.

Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2.

Benaboud S, Pruvost A, Coffie PA, Ekouévi DK, Urien S, Arrivé E, Blanche S, Théodoro F, Avit D, Dabis F, Tréluyer JM, Hirt D.

Antimicrob Agents Chemother. 2011 Mar;55(3):1315-7. doi: 10.1128/AAC.00514-10. Epub 2010 Dec 20.

26.

Drug bioanalysis and biomarker discovery at the Commissariat à l'énergie atomique et aux énergies alternatives.

Ezan E, Becher F, Benech H, Fenaille F, Junot C, Mabondzo A, Pruvost A.

Bioanalysis. 2010 Apr;2(4):713-7. doi: 10.4155/bio.10.16. No abstract available.

27.

Relationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens.

Domingo P, Cabeza MC, Pruvost A, Salazar J, Gutierrez Mdel M, Mateo MG, Domingo JC, Fernandez I, Villarroya F, Muñoz J, Vidal F, Baiget M.

Clin Infect Dis. 2010 Apr 1;50(7):1033-40. doi: 10.1086/651117.

PMID:
20192724
28.

Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir.

Pruvost A, Negredo E, Théodoro F, Puig J, Levi M, Ayen R, Grassi J, Clotet B.

Antimicrob Agents Chemother. 2009 May;53(5):1937-43. doi: 10.1128/AAC.01064-08. Epub 2009 Mar 9.

29.

Direct analysis of valsartan or candesartan in human plasma and urines by on-line solid phase extraction coupled to electrospray tandem mass spectrometry.

Levi M, Wuerzner G, Ezan E, Pruvost A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 1;877(10):919-26. doi: 10.1016/j.jchromb.2009.02.030. Epub 2009 Feb 21.

PMID:
19264560
30.

Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation.

Bousquet L, Pruvost A, Guyot AC, Farinotti R, Mabondzo A.

Antimicrob Agents Chemother. 2009 Mar;53(3):896-902. doi: 10.1128/AAC.00733-08. Epub 2008 Dec 15.

31.

Emtricitabine: Inhibitor and substrate of multidrug resistance associated protein.

Bousquet L, Pruvost A, Didier N, Farinotti R, Mabondzo A.

Eur J Pharm Sci. 2008 Nov 15;35(4):247-56. doi: 10.1016/j.ejps.2008.06.017. Epub 2008 Jul 18.

PMID:
18692133
32.

High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers.

Durand-Gasselin L, Pruvost A, Dehée A, Vaudre G, Tabone MD, Grassi J, Leverger G, Garbarg-Chenon A, Bénech H, Dollfus C.

Antimicrob Agents Chemother. 2008 Jul;52(7):2555-63. doi: 10.1128/AAC.01130-07. Epub 2008 Apr 21.

33.

Biological monitoring of occupational exposure to di(2-ethylhexyl) phthalate: survey of workers exposed to plastisols.

Gaudin R, Marsan P, Robert A, Ducos P, Pruvost A, Lévi M, Bouscaillou P.

Int Arch Occup Environ Health. 2008 Aug;81(8):959-66. Epub 2007 Dec 21.

PMID:
18097680
35.

Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells.

Durand-Gasselin L, Da Silva D, Benech H, Pruvost A, Grassi J.

Antimicrob Agents Chemother. 2007 Jun;51(6):2105-11. Epub 2007 Apr 16.

36.

Development and validation of an LC/MS/MS assay for mycophenolic acid in human peripheral blood mononuclear cells.

Bénech H, Hascoët S, Furlan V, Pruvost A, Durrbach A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):168-74. Epub 2007 Mar 18.

PMID:
17400525
37.

Visualization of ribonucleotide reductase catalytic oxidation establishes thioredoxins as its major reductants in yeast.

Camier S, Ma E, Leroy C, Pruvost A, Toledano M, Marsolier-Kergoat MC.

Free Radic Biol Med. 2007 Apr 1;42(7):1008-16. Epub 2007 Jan 8.

PMID:
17349928
38.

Sensitive and specific LC-ESI-MS/MS method for the determination of a styrylquinoline, BA011FZ041, a potent HIV anti-integrase agent, in rat plasma.

Pruvost A, Levi M, Zouhiri F, Ménier I, Benech H.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 1;850(1-2):259-66. Epub 2006 Dec 8.

PMID:
17161029
39.

Is stavudine triphosphate a natural metabolite of zidovudine?

Benech H, Becher F, Pruvost A, Grassi JJ.

Antimicrob Agents Chemother. 2006 Aug;50(8):2899; author reply 2899-901. No abstract available.

40.
41.

Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients.

Pruvost A, Negredo E, Benech H, Theodoro F, Puig J, Grau E, García E, Moltó J, Grassi J, Clotet B.

Antimicrob Agents Chemother. 2005 May;49(5):1907-14.

42.
43.
44.

Peripheral blood mononuclear cell counting using a DNA-detection-based method.

Benech H, Théodoro F, Herbet A, Page N, Schlemmer D, Pruvost A, Grassi J, Deverre JR.

Anal Biochem. 2004 Jul 1;330(1):172-4. No abstract available.

PMID:
15183777
45.

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load.

Negredo E, Moltó J, Burger D, Viciana P, Ribera E, Paredes R, Juan M, Ruiz L, Puig J, Pruvost A, Grassi J, Masmitjà E, Clotet B.

AIDS. 2004 Feb 20;18(3):459-63.

PMID:
15090798
46.
47.

Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial.

Salmon-Céron D, Lassalle R, Pruvost A, Benech H, Bouvier-Alias M, Payan C, Goujard C, Bonnet E, Zoulim F, Morlat P, Sogni P, Pérusat S, Tréluyer JM, Chêne G; CORIST-ANRS HC1 Study Group.

Clin Infect Dis. 2003 May 15;36(10):1295-304. Epub 2003 May 9.

PMID:
12746776
48.

Liquid chromatography-tandem mass spectrometry assays for intracellular deoxyribonucleotide triphosphate competitors of nucleoside antiretrovirals.

Henneré G, Becher F, Pruvost A, Goujard C, Grassi J, Benech H.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jun 15;789(2):273-81.

PMID:
12742119
49.

Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients.

Becher F, Pruvost AG, Schlemmer DD, Créminon CA, Goujard CM, Delfraissy JF, Benech HC, Grassi JJ.

AIDS. 2003 Mar 7;17(4):555-61.

PMID:
12598776
50.

Development of a direct assay for measuring intracellular AZT triphosphate in humans peripheral blood mononuclear cells.

Becher F, Schlemmer D, Pruvost A, Nevers MC, Goujard C, Jorajuria S, Guerreiro C, Brossette T, Lebeau L, Créminon C, Grassi J, Benech H.

Anal Chem. 2002 Aug 15;74(16):4220-7.

PMID:
12199596

Supplemental Content

Loading ...
Support Center